Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-21 4:51 pm Purchase |
2024-11-19 | 13G | Aclaris Therapeutics, Inc. ACRS |
Vivo Opportunity Fund Holdings, L.P. | 7,955,160 7.400% |
7,955,160 (New Position) |
Filing |